Atb Cap Markets Estimates Cresco Labs Q2 Earnings

Cresco Labs Inc. (OTCMKTS:CRLBF - Free Report) - Stock analysts at Atb Cap Markets issued their Q2 2025 earnings per share estimates for Cresco Labs in a report issued on Wednesday, March 12th. Atb Cap Markets analyst F. Gomes expects that the company will post earnings of ($0.03) per share for the quarter. Atb Cap Markets has a "Hold" rating on the stock. The consensus estimate for Cresco Labs' current full-year earnings is ($0.20) per share. Atb Cap Markets also issued estimates for Cresco Labs' Q3 2025 earnings at ($0.03) EPS and Q4 2025 earnings at ($0.03) EPS.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last issued its quarterly earnings results on Friday, March 14th. The company reported ($0.01) EPS for the quarter, meeting analysts' consensus estimates of ($0.01). The company had revenue of $176.00 million for the quarter, compared to analyst estimates of $172.10 million. Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%.

Separately, Cormark upgraded Cresco Labs from a "hold" rating to a "moderate buy" rating in a report on Monday. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Cresco Labs has an average rating of "Buy" and a consensus target price of $3.00.

Remove Ads

Cresco Labs Stock Down 4.0 %

Shares of Cresco Labs stock traded down $0.03 during trading on Friday, reaching $0.71. The stock had a trading volume of 319,620 shares, compared to its average volume of 590,347. The company has a market capitalization of $344.14 million, a price-to-earnings ratio of -3.53 and a beta of 1.79. The stock has a fifty day moving average price of $0.88 and a two-hundred day moving average price of $1.19. Cresco Labs has a 52 week low of $0.70 and a 52 week high of $2.60. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.